{"id":"W3116093824","doi":"10.1016/j.lungcan.2020.12.026","title":"Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors","year":2020,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Canada; AstraZeneca France; Pfizer; British Microcirculation Society; Boehringer Ingelheim; AbbVie; Roche","keywords":"Medicine; Lung cancer; Incidence (geometry); Internal medicine; Cancer; Response Evaluation Criteria in Solid Tumors; Medical record; Oncology; Retrospective cohort study; Disease; Progressive disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002090028,0.0001603297,0.0002613298,0.001187022,0.0003414366,0.0005186002,0.0004477491,0.0002382912,0.0003944169],"category_scores_gemma":[0.00534373,0.0001000745,0.0003181084,0.00128186,0.0003516365,0.0004759553,0.0005582828,0.0003424826,0.00008250518],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003960291,"about_ca_system_score_gemma":0.0005635475,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009406902,"about_ca_topic_score_gemma":0.001649151,"domain_scores_codex":[0.9986154,0.000401324,0.0003937835,0.0001752414,0.0002996036,0.0001146509],"domain_scores_gemma":[0.9951193,0.0009652714,0.003098658,0.0002005505,0.0004031463,0.0002130553],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003800219,0.00000458294,0.9983118,0.00001329632,0.000009518113,0.00006743373,0.00004215052,0.00003178386,0.00004224296,0.00001242771,0.00004571035,0.001381169],"study_design_scores_gemma":[0.000005384386,0.00005989667,0.9970835,0.00003279235,0.00003165955,0.001475134,0.0003249881,0.0003966231,0.0001694893,0.00005949593,0.0003569395,0.000004099527],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973518,0.001489899,0.00023585,0.00007678836,0.000006194448,0.00002864434,0.0003705571,0.000004048661,0.0004363206],"genre_scores_gemma":[0.9989605,0.0002719812,0.0001677574,0.00001940281,0.000010529,0.00001726555,0.0005299625,0.000001087286,0.00002156866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002090028,"threshold_uncertainty_score":0.0110532,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01077471963902486,"score_gpt":0.2519211103375862,"score_spread":0.2411463906985614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}